Biohaven Acute Migraine Study

Description:

This study is dedicated to evaluating the effectiveness of a medication that treats acute migraine attacks in participants 18+ years of age. The duration of this study is 24 weeks in total and consists of 8 study appointments during that time.  

Qualified Participants are: 

  • Experience on average of 4-14 migraine attacks a month 

Location:

6210 Brandt Pike, Suite 102

Dayton, Ohio 45424

(937) 912-4369

Chronic Migraine Study - Dayton

WellNow Urgent Care & Research partners with multinational pharmaceuticals, biotechnology companies, medical device manufacturers & CROs to help drive improvements to health and well-being. In our 15 years of research, WellNow has had over 17,000 visits to our network of clinical research sites.
Facebook for wellnow research
Youtube for WN research
Twitter for WN Research

© 2022 WELLNOW URGENT CARE & RESEARCH